Larry Phillips, Managing Editor
Over the next 4 weeks, our editorial staff will curate and publish weekly roundups of the most reliable, impartial, solutions-focused journalism around COVID-19. Last week, our focus was on solutions for treatment.
These roundups are made possible and proudly supported by Hudson & Essex.
MANSFIELD — Our weekly goal with this solutions-oriented column is to find ideas that others are floating about how to address the coronavirus.
Richland Source managing editor Larry Phillips. He’s led the Source newsrooms since 2016.
Remember, the goal is to introduce the story and offer a link to explore and make your own judgement.
Hong Kong scientists say new antiviral coating can protect surfaces for 90 days
In a story from Reuters, researchers at a Hong Kong university say they have developed an antiviral coating which could provide 90 days of “significant” protection against bacteria and viruses such as the one causing COVID-19.
New York clinical trial quietly tests heartburn remedy against coronavirus
From Science Magazine.org, reports from China and molecular modeling results suggest that the drug, which seems to bind to a key enzyme in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), could make a difference.
Hydroxychloroquine has 90% chance of helping COVID-19 patients, according to American Physicians & Surgeons (AAPS)
In a story from Yahoo.com, the American Physicians & Sureons reports the total number of reported patients treated with HCQ, with or without zinc and the widely used antibiotic azithromycin, is 2,333, in observational data from China, France, South Korea, Algeria, and the U.S. Of these, 2,137 or 91.6 percent improved clinically. Peer-reviewed studies published from January through April 20, 2020, provide clear and convincing evidence that HCQ may be beneficial in COVID-19, especially when used early, states AAPS.
A ventilator wasn’t enough for this 30-year-old COVID-19 patient, so San Antonio doctors improvised
In Nick’s case, when even medications and a ventilator weren’t enough, he was given extracorporeal membrane oxygenation, or ECMO, which allowed his lungs to rest as a machine took over the job of filtering oxygen into his blood.
Scientists to Stop COVID-19 has designed a 4-stage plan to develop treatments, fast-track a vaccine & reopen U.S. industry
Business Insider reports that a group of scientists, billionaires, and Nobel Prize winners are secretly researching controversial coronavirus treatments and expedited vaccines.
Here’s a new use for an unused school bus
From a website called FastCompany.com, here’s an idea to turn out-of-use school buses into low-cost mobile COVID test labs Designers have made a simple kit that makes a conversion easy. “It’s almost like the Ikea for COVID testing.”
Coronavirus crisis opens access to online opioid addiction treatment
Our friends at the Solutions Journalism network shared this story with us from Kaiser Health News. Officials with the insurer Anthem said using Bright Heart’s telemedicine option has helped increase medication-assisted treatment for members with opioid drug abuse issues from California and nine other states from 16% to more than 30%. While fewer than 5% of Anthem patients seeking addiction treatment use telemedicine, the company expects the option to become more common.
Check back in with us next week and we’ll see what we can find on our next lap around the world in COVID-19.
Do you value our coronavirus coverage?
Facts over fear: That’s been our guiding light as we continue to navigate the uncharted waters of this pandemic.
Whether it’s rounding up the best solutions-focused journalism we can find or reporting locally on COVID-19, if you think we’ve been good stewards, consider a Source Membership today. 100% of your support through our membership program goes to our reporting efforts.
Above all, thank you for continuing to take this journey with us. Stay safe, stay healthy.
Our solutions stories are inspired and powered by our community, including our generous Newsroom Partners and Source members. Help us tell the whole story of our region by becoming a member today.
Be a Source Member